Imipenem/cilastatin/relebactam: A new carbapenem β-lactamase inhibitor combination.

Autor: Mansour H; Department of Pharmacy Practice, School of Pharmacy, Lebanese American University, Byblos, Lebanon., Ouweini AEL; Lebanese American University Medical Center - Rizk Hospital, Beirut, Lebanon.; School of Pharmacy, Lebanese American University, Byblos, Lebanon., Chahine EB; Lloyd L. Gregory School of Pharmacy, Palm Beach Atlantic University, West Palm Beach, FL, USA., Karaoui LR; Department of Pharmacy Practice, School of Pharmacy, Lebanese American University, Byblos, Lebanon.

Publikováno v: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists [Am J Health Syst Pharm] 2021 Mar 31; Vol. 78 (8), pp. 674-683.